FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Masatoshi Tagawa

Research Profile

Living Beings

Anatomy

Tumor Cells, Cultured

Procedures

Physiology

Disorders

Chemicals & Drugs

Devices

Gene Transfer Techniques

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Shinya Okamoto; Hideaki Shimada; Masato Shingyoji; Yuji Tada; Toshihiko Fukamachi; Kenzo Hiroshima; Yuanyuan Jiang; Kiyoko Kawamura; Hiroshi Kobayashi; Yuichi Takiguchi; Koichiro Tatsumi; Masatoshi Tagawa
Zoledronic acid produces combinatory anti-tumor effects with cisplatin on mesothelioma by increasing p53 expression levels.
Yuji Tada; Kenzo Hiroshima; Hideaki Shimada; Masatoshi Tagawa
A potential therapeutic strategy for malignant mesothelioma with gene medicine.
Makako Yamanaka; Sana Yokoi; Yuichi Takiguchi; Koichiro Tatsumi; Naoto Yamaguchi; Kuan Chai; Toshihiko Fukamachi; Kenzo Hiroshima; Kiyoko Kawamura; Atsushi Kitamura; Hiroshi Kobayashi; Quanhai Li; Min Liang; Shinya Okamoto; Hideaki Shimada; Yuji Tada; Masatoshi Tagawa
E1B-55 kDa-defective adenoviruses activate p53 in mesothelioma and enhance cytotoxicity of anticancer agents.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Masatoshi Tagawa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2013: Shinya Okamoto; Hideaki Shimada; Masato Shingyoji; Yuji Tada; Toshihiko Fukamachi; Kenzo Hiroshima; Yuanyuan Jiang; Kiyoko Kawamura; Hiroshi Kobayashi; Yuichi Takiguchi; Koichiro Tatsumi; Masatoshi Tagawa
Zoledronic acid produces combinatory anti-tumor effects with cisplatin on mesothelioma by increasing p53 expression levels.
PloS one 2013;8(3):e60297.
2013: Yuji Tada; Kenzo Hiroshima; Hideaki Shimada; Masatoshi Tagawa
A potential therapeutic strategy for malignant mesothelioma with gene medicine.
BioMed research international 2013;2013():572609.
2012: Makako Yamanaka; Sana Yokoi; Yuichi Takiguchi; Koichiro Tatsumi; Naoto Yamaguchi; Kuan Chai; Toshihiko Fukamachi; Kenzo Hiroshima; Kiyoko Kawamura; Atsushi Kitamura; Hiroshi Kobayashi; Quanhai Li; Min Liang; Shinya Okamoto; Hideaki Shimada; Yuji Tada; Masatoshi Tagawa
E1B-55 kDa-defective adenoviruses activate p53 in mesothelioma and enhance cytotoxicity of anticancer agents.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(12):1850-7.
2012: Miyako Kitazono-Saitoh; Katsushi Kurosu; Emiko Sakaida; Ikuo Sekine; Yuji Tada; Masatoshi Tagawa; Yuichi Takiguchi; Nobuhiro Tanabe; Hironori Ashinuma; Atsushi Kitamura; Satoru Kitazono; Koichiro Tatsumi
Interaction and cross-resistance of cisplatin and pemetrexed in malignant pleural mesothelioma cell lines.
Oncology reports 2012;28(1):33-40.
2012: Hiroyasu Nagakawa; Osamu Shimozato; Yuji Tada; Yuichi Takiguchi; Koichiro Tatsumi; Akihiko Wada; Ling Yu; Sunil Chada; Kiyoko Kawamura; Quanhai Li; Masatoshi Tagawa
Expression of a murine homolog of apoptosis-inducing human IL-24/MDA-7 in murine tumors fails to induce apoptosis or produce anti-tumor effects.
Cellular immunology 2012;275(1-2):90-7.
2011: Atsushi Kitamura; David Levens; Hisahiro Matsubara; Kazuyuki Matsushita; Mamoru Hasegawa; Kenzo Hiroshima; Makoto Inoue; Yasunori Sato; Hideaki Shimada; Yuji Tada; Masatoshi Tagawa; Yuichi Takiguchi; Koichiro Tatsumi; Takeshi Tomonaga; Makako Yamanaka; Fumio Nomura
Synergistic effect of non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor plus cisplatin in the treatment of malignant pleural mesothelioma.
Cancer science 2011;102(7):1366-73.
2011: Masatoshi Tagawa; Yuji Tada; Kenzo Hiroshima; Kiyoko Kawamura; Quanhai Li; Hideaki Shimada
A possible anticancer agent, type III interferon, activates cell death pathways and produces antitumor effects.
Clinical & developmental immunology 2011;2011():479013.
2010: Toshihiko Fukamachi; Yoshie Chiba; Xin Wang; Hiromi Saito; Masatoshi Tagawa; Hiroshi Kobayashi
Tumor specific low pH environments enhance the cytotoxicity of lovastatin and cantharidin.
Cancer letters 2010;297(2):182-9.
2010: Quanhai Li; Kiyoko Kawamura; Guangyu Ma; Fumi Iwata; Muneo Numasaki; Nobuo Suzuki; Hideaki Shimada; Masatoshi Tagawa
Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents.
European journal of cancer (Oxford, England : 1990) 2010;46(1):180-90.
2009: Osamu Shimozato; Ayako Sato; Kiyoko Kawamura; Masako Chiyo; Guangyu Ma; Quanhai Li; Masatoshi Tagawa
The secreted form of p28 subunit of interleukin (IL)-27 inhibits biological functions of IL-27 and suppresses anti-allogeneic immune responses.
Immunology 2009;128(1 Suppl):e816-25.
2009: Guangyu Ma; Hideaki Shimada; Kenzo Hiroshima; Yuji Tada; Nobuo Suzuki; Masatoshi Tagawa
Gene medicine for cancer treatment: commercially available medicine and accumulated clinical data in China.
Drug design, development and therapy 2009;2():115-22.
2008: Hideaki Shimada; Kazuyuki Matsushita; Masatoshi Tagawa
Recent advances in esophageal cancer gene therapy.
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 2008;14(1):3-8.
2008: Yuji Tada; Yuichi Takiguchi; Kenzo Hiroshima; Hideaki Shimada; Taro Ueyama; Makoto Nakamura; Koichiro Tatsumi; Takayuki Kuriyama; Masatoshi Tagawa
Gene therapy for malignant pleural mesothelioma: present and future.
Oncology research 2008;17(6):239-46.
2008: Masatoshi Tagawa; Kiyoko Kawamura; Taro Ueyama; Makoto Nakamura; Yuji Tada; Guangyu Ma; Quanhai Li; Nobuo Suzuki; Hideaki Shimada; Tekenori Ochiai
Cancer therapy with local oncolysis and topical cytokine secretion.
Frontiers in bioscience : a journal and virtual library 2008;13():2578-87.
2007: Ling Yu; Osamu Shimozato; Quanhai Li; Kiyoko Kawamura; Guangyu Ma; Masayoshi Namba; Tomoko Ogawa; Ikuo Kaiho; Masatoshi Tagawa
Adenovirus type 5 substituted with type 11 or 35 fiber structure increases its infectivity to human cells enabling dual gene transfer in CD46-dependent and -independent manners.
Anticancer research 2007;27(4B):2311-6.
2007: Akihiko Wada; Yuji Tada; Kiyoko Kawamura; Yuichi Takiguchi; Koichiro Tatsumi; Takayuki Kuriyama; T Takenouchi; Jiyang O-Wang; Masatoshi Tagawa
The effects of FasL on inflammation and tumor survival are dependent on its expression levels.
Cancer gene therapy 2007;14(3):262-7.
2007: Kiyoko Kawamura; Ling Yu; Minoru Tomizawa; Osamu Shimozato; Guangyu Ma; Quanhai Li; Ayako Sato; Yanling Yang; Takeo Suzuki; Nashwa Mohamed Abdel-Aziz; Masatoshi Tagawa
Transcriptional regulatory regions of the survivin gene activate an exogenous suicide gene in human tumors and enhance the sensitivity to a prodrug.
Anticancer research 2007;27(1A):89-93.
2006: Masatoshi Tagawa; Kiyoko Kawamura; Osamu Shimozato; Guangyu Ma; Quanhai Li; Nobuo Suzuki; Hideaki Shimada; Takenori Ochiai
Virology- and immunology-based gene therapy for cancer.
Cancer immunology, immunotherapy : CII 2006;55(11):1420-5.
2006: Osamu Shimozato; Shin-ichi Ugai; Masako Chiyo; Hisanori Takenobu; Hiroyasu Nagakawa; Akihiko Wada; Kiyoko Kawamura; Hiroshi Yamamoto; Masatoshi Tagawa
The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects.
Immunology 2006;117(1):22-8.
2005: Ling Yu; Hisanori Takenobu; Osamu Shimozato; Kiyoko Kawamura; Yoshinori Nimura; Naohiko Seki; Katsuhiro Uzawa; Hideki Tanzawa; Hideaki Shimada; Takenori Ochiai; Masatoshi Tagawa
Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cells.
Oncology reports 2005;14(4):831-5.
2005: Masahiko Nezu; Takeshi Tomonaga; Chikara Sakai; Akihiro Ishii; Sakae Itoga; Miki Nishimura; Yoshinobu Matsuo; Masatoshi Tagawa; Fumio Nomura
Expression of the fetal-oncogenic fibroblast growth factor-8/17/18 subfamily in human hematopoietic tumors.
Biochemical and biophysical research communications 2005;335(3):843-9.
2005: Masako Chiyo; Osamu Shimozato; Ling Yu; Kiyoko Kawamura; Toshihiko Iizasa; Takehiko Fujisawa; Masatoshi Tagawa
Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals.
International journal of cancer. Journal international du cancer 2005;115(3):437-42.
2005: Yasuo Iwadate; Makoto Inoue; Takashi Saegusa; Yumiko Tokusumi; Hiroaki Kinoh; Mamoru Hasegawa; Masatoshi Tagawa; Akira Yamaura; Hideaki Shimada
Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(10):3821-7.
2004: Masako Chiyo; Osamu Shimozato; Toshihiko Iizasa; Takehiko Fujisawa; Masatoshi Tagawa
Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells.
Anticancer research 2004;24(6):3763-7.
2004: H Nagakawa; Osamu Shimozato; Ling Yu; Yuichi Takiguchi; Koichiro Tatsumi; Takayuki Kuriyama; Masatoshi Tagawa
Expression of interleukin-22 in murine carcinoma cells did not influence tumour growth in vivo but did improve survival of the inoculated hosts.
Scandinavian journal of immunology 2004;60(5):449-54.
2004: Akihiko Wada; Yuji Tada; Osamu Shimozato; Yuichi Takiguchi; Koichiro Tatsumi; Takayuki Kuriyama; Masatoshi Tagawa
Expression of CD40 ligand in CD40-positive murine tumors activates transcription of the interleukin-23 subunit genes and produces antitumor responses.
Anticancer research 2004;24(5A):2713-6.
2004: Haruko Yamaji; Toshihiko Iizasa; Eitetsu Koh; Makoto Suzuki; Mizuto Otsuji; Hao Chang; Shinichiro Motohashi; Sana Yokoi; Kenzo Hiroshima; Masatoshi Tagawa; Toshinori Nakayama; Takehiko Fujisawa
Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer.
Cancer immunology, immunotherapy : CII 2004;53(9):786-92.
2004: Ling Yu; K Hamada; M Namba; Kenji Kadomatsu; T Muramatsu; S Matsubara; Masatoshi Tagawa
Midkine promoter-driven suicide gene expression and -mediated adenovirus replication produced cytotoxic effects to immortalised and tumour cells.
European journal of cancer (Oxford, England : 1990) 2004;40(11):1787-94.
2004: Yanqing Wang; Mika Seimiya; Kiyoko Kawamura; Ling Yu; Tomoo Ogi; Keizo Takenaga; Tomotane Shishikura; Akira Nakagawara; Shigeru Sakiyama; Masatoshi Tagawa; Jiyang O-Wang
Elevated expression of DNA polymerase kappa in human lung cancer is associated with p53 inactivation: Negative regulation of POLK promoter activity by p53.
International journal of oncology 2004;25(1):161-5.
2004: Mika Seimiya; Akihiko Wada; Kiyoko Kawamura; Akemi Sakamoto; Yusuke Ohkubo; Seiji Okada; Masahiko Hatano; Takeshi Tokuhisa; Takeshi Watanabe; Hiromitsu Saisho; Masatoshi Tagawa; Jiyang O-Wang
Impaired lymphocyte development and function in Clast5/Stra13/DEC1-transgenic mice.
European journal of immunology 2004;34(5):1322-32.
2004: Kiyoko Kawamura; Rumana Bahar; Mika Seimiya; Masako Chiyo; Akihiko Wada; Seiji Okada; Masahiko Hatano; Takeshi Tokuhisa; Hideki Kimura; Satoshi Watanabe; Ichiro Honda; Shigeru Sakiyama; Masatoshi Tagawa; Jiyang O-Wang
DNA polymerase theta is preferentially expressed in lymphoid tissues and upregulated in human cancers.
International journal of cancer. Journal international du cancer 2004;109(1):9-16.
2004: Ling Yu; Katsuyuki Hamada; Masayoshi Namba; Kenji Kadomatsu; Takashi Muramatsu; Shuichiro Matsubara; Masatoshi Tagawa
Insertion of an exogenous promoter in the E1A regulatory region of adenovirus does not disturb viral replication despite reduced E1A transcription.
Cancer letters 2004;203(1):51-7.
2004: Baoen Shan; Ling Yu; Osamu Shimozato; Qiaoxia Li; Masatoshi Tagawa
Expression of interleukin-21 and -23 in human esophageal tumors produced antitumor effects in nude mice.
Anticancer research 2004;24(1):79-82.
2003: Shin-ichi Ugai; Osamu Shimozato; Ling Yu; Yan-Qing Wang; Kiyoko Kawamura; Hiroshi Yamamoto; Taketo Yamaguchi; Hiromitsu Saisho; Shigeru Sakiyama; Masatoshi Tagawa
Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects.
Cancer gene therapy 2003;10(10):771-8.
2003: Ling Yu; Shin-ichi Ugai; Jiyang O-Wang; Masayoshi Namba; Kenji Kadomatsu; Takashi Muramatsu; Shuichiro Matsubara; Shigeru Sakiyama; Masatoshi Tagawa
Cell growth- and P53-dependent transcriptional activity of the midkine promoter confers suicide gene expression in tumor cells.
Oncology reports 2003;10(5):1301-5.
2003: Yasuo Iwadate; Akira Yamaura; Shigeru Sakiyama; Yasuo Sato; Masatoshi Tagawa
Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
International journal of oncology 2003;23(2):483-8.
2003: Yan-Qing Wang; Shin-ichi Ugai; Osamu Shimozato; Ling Yu; Kiyoko Kawamura; Hiroshi Yamamoto; Taketo Yamaguchi; Hiromitsu Saisho; Masatoshi Tagawa
Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells.
International journal of cancer. Journal international du cancer 2003;105(6):820-4.
2003: Minoru Tomizawa; Hiromitsu Saisho; Masatoshi Tagawa
Regulatory regions of growth-related genes can activate an exogenous gene of the alpha-fetoprotein promoter to a comparable degree in human hepatocellular carcinoma cells.
Anticancer research 2003;23(4):3273-7.
2003: Hideaki Shimada; Yoshihiro Nabeya; Masatoshi Tagawa; Shinichi Okazumi; Hisahiro Matsubara; Kenji Kadomatsu; Takashi Muramatsu; Shinya Ikematsu; Sadatoshi Sakuma; Takenori Ochiai
Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma.
Cancer science 2003;94(7):628-32.
2003: Yan-Qing Wang; Akihiko Wada; Shin-ichi Ugai; Masatoshi Tagawa
Expression of the Mig (CXCL9) gene in murine lung carcinoma cells generated angiogenesis-independent antitumor effects.
Oncology reports 2003;10(4):909-13.
2003: Yuji Tada; Jiyang O-Wang; Ling Yu; Osamu Shimozato; Yan-Qing Wang; Yuichi Takiguchi; Koichiro Tatsumi; Takayuki Kuriyama; Keizo Takenaga; Shigeru Sakiyama; Masatoshi Tagawa
T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines.
Cancer gene therapy 2003;10(6):451-6.
2003: Shin-ichi Ugai; Osamu Shimozato; Kiyoko Kawamura; Yan-Qing Wang; Taketo Yamaguchi; Hiromitsu Saisho; Shigeru Sakiyama; Masatoshi Tagawa
Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts.
Cancer gene therapy 2003;10(3):187-92.
2003: Yuji Tada; Jiyang O-Wang; Akihiko Wada; Yuichi Takiguchi; Koichiro Tatsumi; Takayuki Kuriyama; Shigeru Sakiyama; Masatoshi Tagawa
Fas ligand-expressing tumors induce tumor-specific protective immunity in the inoculated hosts but vaccination with the apoptotic tumors suppresses antitumor immunity.
Cancer gene therapy 2003;10(2):134-40.
2003: Mika Seimiya; Jiyang O-Wang; Rumana Bahar; Kiyoko Kawamura; Yanqing Wang; Hiromitsu Saisho; Masatoshi Tagawa
Stage-specific expression of Clast6/E3/LAPTM5 during B cell differentiation: elevated expression in human B lymphomas.
International journal of oncology 2003;22(2):301-4.
2003: Minoru Tomizawa; Kazuo Watanabe; Hiromitsu Saisho; Akira Nakagawara; Masatoshi Tagawa
Down-regulated expression of the CCAAT/enhancer binding protein alpha and beta genes in human hepatocellular carcinoma: a possible prognostic marker.
Anticancer research 2003;23(1A):351-4.
2002: Yasuo Iwadate; Hiroki Namba; Shigeru Sakiyama; Akira Yamaura; Masatoshi Tagawa
Interleukin-12-mediated induction of systemic immunity in the periphery and recruitment of activated T cells into the brain produce limited antitumor effects compared with interleukin-2.
International journal of molecular medicine 2002;10(6):741-7.
2002: Rumana Bahar; Jiyang O-Wang; Kiyoko Kawamura; Mika Seimiya; Yanqing Wang; Masahiko Hatano; Seiji Okada; Takeshi Tokuhisa; Takeshi Watanabe; Masatoshi Tagawa
Growth retardation, polyploidy, and multinucleation induced by Clast3, a novel cell cycle-regulated protein.
The Journal of biological chemistry 2002;277(42):40012-9.
2002: Yuji Tada; Jiyang O-Wang; Yuichi Takiguchi; Koichiro Tatsumi; Takayuki Kuriyama; Seiji Okada; Takeshi Tokuhisa; Shigeru Sakiyama; Masatoshi Tagawa
Cutting edge: a novel role for Fas ligand in facilitating antigen acquisition by dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(5):2241-5.
2002: Minoru Tomizawa; Yan-Qing Wang; Masaaki Ebara; Hiromitsu Saisho; Kazuo Watanabe; Akira Nakagawara; Masatoshi Tagawa
Decreased expression of the CCAAT/enhancer binding protein alpha gene involved in hepatocyte proliferation in human hepatocellular carcinomas.
International journal of molecular medicine 2002;9(6):597-600.
2002: Jiyang O-Wang; Kagemasa Kajiwara; Kiyoko Kawamura; Minoru Kimura; Hiro Miyagishima; Haruhiko Koseki; Masatoshi Tagawa
An essential role for REV3 in mammalian cell survival: absence of REV3 induces p53-independent embryonic death.
Biochemical and biophysical research communications 2002;293(3):1132-7.
2002: Yuji Tada; Jiyang O-Wang; Keizo Takenaga; Yuichi Takiguchi; Koichiro Tatsumi; Takayuki Kuriyama; Masatoshi Tagawa
Expression of the TNF-alpha gene on mouse lung carcinoma cells suppresses spontaneous lung metastasis without affecting tumorigenicity.
Oncology reports 2002;9(3):585-8.
2002: Mika Seimiya; Rumana Bahar; Yanqing Wang; Kiyoko Kawamura; Yuji Tada; Seiji Okada; Masahiko Hatano; Takeshi Tokuhisa; Hiromitsu Saisho; Takeshi Watanabe; Masatoshi Tagawa; Jiyang O-Wang
Clast5/Stra13 is a negative regulator of B lymphocyte activation.
Biochemical and biophysical research communications 2002;292(1):121-7.
2002: Yuji Tada; Jiyang O-Wang; Mika Seimiya; Yuichi Takiguchi; Koichiro Tatsumi; Takayuki Kuriyama; Masatoshi Tagawa
Antitumor effects are produced by forced expression of membrane-bound but not soluble Fas ligand in murine lung carcinoma cells.
Anticancer research 2002;22(2A):831-6.
2002: Yuji Tada; Jiyang O-Wang; Yuichi Takiguchi; Koichiro Tatsumi; Takayuki Kuriyama; Masatoshi Tagawa
T cell dependent and independent antitumor immunity generated by the expression of Fas ligand on mouse lung carcinoma cells.
International journal of molecular medicine 2002;9(3):281-5.
2002: Ling Yu; Sakurako Kamo; Masatoshi Tagawa
Identification of a minimal c-erbB-2 promoter region that mediates preferential expression of a linked foreign gene in human breast cancer cells.
International journal of oncology 2002;20(3):607-10.
2002: Yu Yoshida; Minoru Tomizawa; Rumana Bahar; Motohiro Miyauchi; Taketo Yamaguchi; Hiromitsu Saisho; Kenji Kadomatsu; Takashi Muramatsu; Shuichiro Matsubara; Shigeru Sakiyama; Masatoshi Tagawa
A promoter region of midkine gene can activate transcription of an exogenous suicide gene in human pancreatic cancer.
Anticancer research 2002;22(1A):117-20.
2002: Kiyoko Kawamura; Rumana Bahar; Waka Natsume; Shigeru Sakiyama; Masatoshi Tagawa
Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
Cancer gene therapy 2002;9(1):109-15.
2001: Yasuo Iwadate; Akira Yamaura; Y Sato; Shigeru Sakiyama; Masatoshi Tagawa
Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
Cancer research 2001;61(24):8769-74.
2001: M Narita; Rumana Bahar; Masahiko Hatano; M M Kang; Takeshi Tokuhisa; S Goto; Hiromitsu Saisho; Shigeru Sakiyama; Masatoshi Tagawa
Tissue-specific expression of a suicide gene for selective killing of neuroblastoma cells using a promoter region of the NCX gene.
Cancer gene therapy 2001;8(12):997-1002.
2001: M Tomizawa; Masaaki Ebara; Hiromitsu Saisho; Shigeru Sakiyama; Masatoshi Tagawa
Irradiation with ultrasound of low output intensity increased chemosensitivity of subcutaneous solid tumors to an anti-cancer agent.
Cancer letters 2001;173(1):31-5.
2001: Jiyang O-Wang; K Kawamura; Y Tada; H Ohmori; H Kimura; Shigeru Sakiyama; Masatoshi Tagawa
DNA polymerase kappa, implicated in spontaneous and DNA damage-induced mutagenesis, is overexpressed in lung cancer.
Cancer research 2001;61(14):5366-9.
2001: Hisahiro Matsubara; Yoshio Gunji; T Maeda; K Tasaki; Y Koide; Takehide Asano; Takenori Ochiai; Shigeru Sakiyama; Masatoshi Tagawa
Electroporation-mediated transfer of cytokine genes into human esophageal tumors produces anti-tumor effects in mice.
Anticancer research 2001;21(4A):2501-3.
2001: Hisahiro Matsubara; T Maeda; Yoshio Gunji; Y Koide; Takehide Asano; Takenori Ochiai; Shigeru Sakiyama; Masatoshi Tagawa
Combinatory anti-tumor effects of electroporation-mediated chemotherapy and wild-type p53 gene transfer to human esophageal cancer cells.
International journal of oncology 2001;18(4):825-9.
2001: Motohiro Miyauchi; Yu Yoshida; Yuji Tada; M Narita; T Maeda; Rumana Bahar; Kenji Kadomatsu; Takashi Muramatsu; Shuichiro Matsubara; Akira Nakagawara; Shigeru Sakiyama; Masatoshi Tagawa
Expression of herpes simplex virus-thymidine kinase gene controlled by a promoter region of the midkine gene confers selective cytotoxicity to ganciclovir in human carcinoma cells.
International journal of cancer. Journal international du cancer 2001;91(5):723-7.
2001: Hideaki Shimada; Takanori Shimizu; Takenori Ochiai; Tian-Ling Liu; Hiroshi Sashiyama; A Nakamura; Hisahiro Matsubara; Yoshio Gunji; Susumu Kobayashi; Masatoshi Tagawa; S Sakiyama; Takaki Hiwasa
Preclinical study of adenoviral p53 gene therapy for esophageal cancer.
Surgery today 2001;31(7):597-604.
2001: Kiyoko Kawamura; Rumana Bahar; H Namba; Mika Seimiya; Keizo Takenaga; H Hamada; Shigeru Sakiyama; Masatoshi Tagawa
Bystander effect in uracil phosphoribosyltransferase/5-fluorouracil-mediated suicide gene therapy is correlated with the level of intercellular communication.
International journal of oncology 2001;18(1):117-20.
2001: Kiyoko Kawamura; Jiyang O-Wang; Rumana Bahar; N Koshikawa; Tomotane Shishikura; Akira Nakagawara; Shigeru Sakiyama; K Kajiwara; M Kimura; Masatoshi Tagawa
The error-prone DNA polymerase zeta catalytic subunit (Rev3) gene is ubiquitously expressed in normal and malignant human tissues.
International journal of oncology 2001;18(1):97-103.
2000: Yasuo Iwadate; Masatoshi Tagawa; H Namba; M Oga; Kiyoko Kawamura; K Tasaki; Shigeru Sakiyama; A Yamaura
Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
Cancer gene therapy 2000;7(9):1263-9.
2000: Masatoshi Tagawa; T Yamaguchi; Osamu Yokosuka; Shoichi Matsutani; T Maeda; Hiromitsu Saisho
Inactivation of a hepadnavirus by electrolysed acid water.
The Journal of antimicrobial chemotherapy 2000;46(3):363-8.
2000: Yasuo Iwadate; S Mochizuki; Shigeru Fujimoto; H Namba; Shigeru Sakiyama; Masatoshi Tagawa; Akira Yamaura
Alteration of CDKN2/p16 in human astrocytic tumors is related with increased susceptibility to antimetabolite anticancer agents.
International journal of oncology 2000;17(3):501-5.
2000: Kiyoko Kawamura; H Namba; Rumana Bahar; Motohiro Miyauchi; T Maeda; H Hamada; Shigeru Sakiyama; Masatoshi Tagawa
Transduction of the human deoxycytidine kinase gene in rodent tumor cells induces in vivo growth retardation in syngeneic hosts.
Cancer letters 2000;156(2):151-7.
2000: N Koshikawa; Keizo Takenaga; Masatoshi Tagawa; Shigeru Sakiyama
Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells.
Cancer research 2000;60(11):2936-41.
2000: T Tomita; Osamu Yokosuka; Masatoshi Tagawa; Hiromitsu Saisho; S Tamura; I Fukuda; Masao Omata
Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses.
Journal of hepatology 2000;32(5):850-8.
2000: Kiyoko Kawamura; K Tasaki; H Hamada; Keizo Takenaga; Shigeru Sakiyama; Masatoshi Tagawa
Expression of Escherichia coli uracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity.
Cancer gene therapy 2000;7(4):637-43.
2000: T Maeda; Hisahiro Matsubara; Y Koide; M Sugaya; Yukimasa Miyazawa; K Tasaki; Kaichi Isono; Takenori Ochiai; Shigeru Sakiyama; Masatoshi Tagawa
Radiosensitivity of human breast cancer cells transduced with wild-type p53 gene is influenced by the p53 status of parental cells.
Anticancer research 2000;20(2A):869-74.
2000: Yu Yoshida; K Tasaki; M Miyauchi; M Narita; Keizo Takenaga; Hiroshi Yamamoto; T Yaaguchi; Hiromitsu Saisho; Shigeru Sakiyama; Masatoshi Tagawa
Impaired tumorigenicity of human pancreatic cancer cells retrovirally transduced with interleukin-12 or interleukin-15 gene.
Cancer gene therapy 2000;7(2):324-31.
2000: K Tasaki; Yu Yoshida; M Miyauchi; T Maeda; Keizo Takenaga; Teruo Kouzu; Takehide Asano; Takenori Ochiai; S Sakiyamna; Masatoshi Tagawa
Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hosts.
Cancer gene therapy 2000;7(2):255-61.
2000: K Tasaki; Yu Yoshida; T Maeda; M Miyauchi; Kiyoko Kawamura; Keizo Takenaga; Hiroshi Yamamoto; Teruo Kouzu; Takehide Asano; Takenori Ochiai; Shigeru Sakiyama; Masatoshi Tagawa
Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells.
Cancer gene therapy 2000;7(2):247-54.
2000: M Narita; K Takanaga; Yu Yoshida; Kenji Kadomatsu; Takashi Muramatsu; Shuichiro Matsubara; H Hamada; S Goto; Hiromitsu Saisho; Shigeru Sakiyama; Masatoshi Tagawa
Polyadenylation signal facilitates the expression of foreign gene that is driven by an internal promoter located in the reverse orientation to long terminal repeat of retrovirus.
Anticancer research 2000;20(1A):279-82.
2000: T Seta; Osamu Yokosuka; Fumio Imazeki; Masatoshi Tagawa; Hiromitsu Saisho
Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients.
Journal of medical virology 2000;60(1):8-16.
1999: S Mochizuki; Y Iwadate; H Namba; Y Yoshida; A Yamaura; Shigeru Sakiyama; Masatoshi Tagawa
Homozygous deletion of the p16/MTS-1/CDKN2 gene in malignant gliomas is infrequent among Japanese patients.
International journal of oncology 1999;15(5):983-9.
1999: T Maeda; Hisahiro Matsubara; M Sugaya; Y Miyazawa; Yoshio Gunji; Takenori Ochiai; Shigeru Sakiyama; Masatoshi Tagawa
Loss of tumorigenicity of human breast cancer cells engineered to produce IL-2, IL-4 or GM-CSF in nude mice.
International journal of oncology 1999;15(5):943-7.
1999: Hisahiro Matsubara; Kiyoko Kawamura; M Sugaya; Y Koide; Yoshio Gunji; Keizo Takenaga; Takehide Asano; Takenori Ochiai; Shigeru Sakiyama; Masatoshi Tagawa
Differential efficacy of suicide gene therapy by herpes simplex virus-thymidine kinase gene reflects the status of p53 gene in human esophageal cancer cells.
Anticancer research 1999;19(5B):4157-60.
1999: H Yoshida; M Tanabe; M Miyauchi; Kiyoko Kawamura; Keizo Takenaga; N Ohnuma; Shigeru Sakiyama; Masatoshi Tagawa
Induced immunity by expression of interleukin-2 or GM-CSF gene in murine neuroblastoma cells can generate antitumor response to established tumors.
Cancer gene therapy 1999;6(5):395-401.
1999: Osamu Yokosuka; H Kojima; Fumio Imazeki; Masatoshi Tagawa; Hiromitsu Saisho; S Tamatsukuri; Masao Omata
Spontaneous negativation of serum hepatitis C virus RNA is a rare event in type C chronic liver diseases: analysis of HCV RNA in 320 patients who were followed for more than 3 years.
Journal of hepatology 1999;31(3):394-9.
1999: M Kimura; Yu Yoshida; M Narita; K Takenaga; T Takenouchi; Taketo Yamaguchi; Hiromitsu Saisho; Shigeru Sakiyama; Masatoshi Tagawa
Acquired immunity in nude mice induced by expression of the IL-2 or IL-4 gene in human pancreatic carcinoma cells and anti-tumor effect generated by in vivo gene transfer using retrovirus.
International journal of cancer. Journal international du cancer 1999;82(4):549-55.
1999: Hisahiro Matsubara; M Kimura; M Sugaya; Y Koide; Yoshio Gunji; K Takegana; Takehide Asano; Takenori Ochiai; K Isono; Shigeru Sakiyama; Masatoshi Tagawa
Expression of wild-type p53 gene confers increased sensitivity to radiation and chemotherapeutic agents in human esophageal carcinoma cells.
International journal of oncology 1999;14(6):1081-5.
1999: M Miyauchi; Hideaki Shimada; Kenji Kadomatsu; Takashi Muramatsu; S Matsubara; Shinya Ikematsu; Keizo Takenaga; Takehide Asano; Takenori Ochiai; Shigeru Sakiyama; Masatoshi Tagawa
Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy.
Japanese journal of cancer research : Gann 1999;90(4):469-75.
1999: A Honda; Osamu Yokosuka; T Ehata; Masatoshi Tagawa; Fumio Imazeki; Hiromitsu Saisho
Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: comparison with mutations in precore and core regions in relation to clinical status.
Journal of medical virology 1999;57(4):337-44.
1998: Hisahiro Matsubara; Y Koide; M Sugaya; Yoshio Gunji; Takehide Asano; Takenori Ochiai; K Takegana; Shigeru Sakiyama; Masatoshi Tagawa
Antitumor response of genetically engineered IL-2 expression to human esophageal carcinoma cells in mature T cell-defective condition.
International journal of oncology 1998;13(6):1217-22.
1998: Yoshio Gunji; K Tasaki; Masatoshi Tagawa; Hisahiro Matsubara; Keizo Takenaga; Takeo Suzuki; Takehide Asano; Takenori Ochiai; Kaichi Isono; Shigeru Sakiyama
Inhibition of peritoneal dissemination of murine colon carcinoma cells by administrating retrovirus harboring IL-2 gene.
Cancer gene therapy 1998;5(6):339-43.
1998: Tatsuo Kanda; Osamu Yokosuka; Masatoshi Tagawa; S Kawai; Fumio Imazeki; Hiromitsu Saisho
Quantitative analysis of GBV-C RNA in liver and serum by strand-specific reverse transcription-polymerase chain reaction.
Journal of hepatology 1998;29(5):707-14.
1998: Kenichi Fukai; Osamu Yokosuka; Keiichi Fujiwara; Masatoshi Tagawa; Fumio Imazeki; Hiromitsu Saisho; Masao Omata
Etiologic considerations of fulminant non-A, non-B viral hepatitis in Japan: analyses by nucleic acid amplification method.
The Journal of infectious diseases 1998;178(2):325-33.
1998: H Yoshida; H Enomoto; Kiyoko Kawamura; Keizo Takenaga; M Tanabe; N Ohnuma; Shigeru Sakiyama; Masatoshi Tagawa
Antitumor vaccine effect of irradiated murine neuroblastoma cells producing interleukin-2 or granulocyte macrophage-colony stimulating factor.
International journal of oncology 1998;13(1):73-8.
1998: M Kimura; Masatoshi Tagawa; K Takenaga; F Kondo; T Yamaguchi; Hiromitsu Saisho; Akira Nakagawara; Shigeru Sakiyama
Loss of tumorigenicity of human pancreatic carcinoma cells engineered to produce interleukin-2 or interleukin-4 in nude mice: a potentiality for cancer gene therapy.
Cancer letters 1998;128(1):47-53.
1998: A Okamura; Y Ohmura; Md Muzharul Islam; Masatoshi Tagawa; K Horitsu; Y Moriyama; Shinji Fujimura
Increased hepatic nicotinamide N-methyltransferase activity as a marker of cancer cachexia in mice bearing colon 26 adenocarcinoma.
Japanese journal of cancer research : Gann 1998;89(6):649-56.
1998: K Tasaki; Yoshio Gunji; Hisahiro Matsubara; Keizo Takenaga; Takeo Suzuki; Takehide Asano; Takenori Ochiai; Kaichi Isono; Teruo Kouzu; Shigeru Sakiyama; Masatoshi Tagawa
Induction of T cell dependent acquired immunity in syngeneic mice by the combined expression of interleukin-4 and granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cells.
Anticancer research 1998;18(3A):1453-6.
1998: H Yoshida; H Enomoto; M Miyauchi; Keizo Takenaga; M Tanabe; N Ohnuma; Shigeru Sakiyama; Masatoshi Tagawa
Impaired tumorigenicity of IL-4-producing murine neuroblastoma cells in immunodeficient nude mice.
International journal of oncology 1998;12(5):1067-71.
1998: H Namba; Yasuo Iwadate; M Iyo; K Fukushi; T Irie; K Sueyoshi; Masatoshi Tagawa; Shigeru Sakiyama
Glucose and methionine uptake by rat brain tumor treated with prodrug-activated gene therapy.
Nuclear medicine and biology 1998;25(3):247-50.
1998: K Tasaki; Masatoshi Tagawa; Yoshio Gunji; Hisahiro Matsubara; Keizo Takenaga; M Muramatsu; S Fujimura; Takeo Suzuki; Takehide Asano; Takenori Ochiai; Kaichi Isono; Teruo Kouzu; Shigeru Sakiyama
Inhibition of experimental lung metastasis of murine colon carcinoma cells depends on the amount of interleukin-2 secreted from the transduced cells.
Anticancer research 1998;18(2A):813-7.
1998: H Yoshida; H Enomoto; Masatoshi Tagawa; Keizo Takenaga; K Tasaki; A Nakagawara; N Ohnuma; H Takahashi; Shigeru Sakiyama
Impaired tumorigenicity and decreased liver metastasis of murine neuroblastoma cells engineered to secrete interleukin-2 or granulocyte macrophage colony-stimulating factor.
Cancer gene therapy 1998;5(2):67-73.
1998: Yasuo Iwadate; Masatoshi Tagawa; S Fujimoto; M Hirose; H Namba; K Sueyoshi; Shigeru Sakiyama; Akira Yamaura
Mutation of the p53 gene in human astrocytic tumours correlates with increased resistance to DNA-damaging agents but not to anti-microtubule anti-cancer agents.
British journal of cancer 1998;77(4):547-51.
1998: M Sugaya; Masatoshi Tagawa; Hisahiro Matsubara; Yoshio Gunji; Keizo Takenaga; T Maeda; Y Koide; Takehide Asano; Takenori Ochiai; K Isono; Shigeru Sakiyama
Induction of antitumor effect on human esophageal carcinoma cells by the retroviral expression of granulocyte macrophage-colony stimulating factor gene.
International journal of oncology 1998;12(2):321-4.
1998: Yu Yoshida; K Tasaki; M Kimurai; Keizo Takenaga; Hiroshi Yamamoto; Taketo Yamaguchi; Hiromitsu Saisho; Shigeru Sakiyama; Masatoshi Tagawa
Antitumor effect of human pancreatic cancer cells transduced with cytokine genes which activate Th1 helper T cells.
Anticancer research 1998;18(1A):333-5.
1998: M Kimura; Masatoshi Tagawa; Yu Yoshida; T Takenouchi; Keizo Takenaga; K Azuma; Taketo Yamaguchi; Hiromitsu Saisho; Shigeru Sakiyama
Impaired in vivo tumor growth of human pancreatic carcinoma cells retrovirally transduced with GM-CSF gene.
Anticancer research 1998;18(1A):165-70.
1998: H Namba; Masatoshi Tagawa; Yasuo Iwadate; M Kimura; K Sueyoshi; Shigeru Sakiyama
Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells.
Human gene therapy 1998;9(1):5-11.
1997: K Tasaki; Yu Yoshida; Masatoshi Tagawa; Keizo Takenaga; Takehide Asano; Takenori Ochiai; Kaichi Isono; Teruo Kouzu; Hiromitsu Saisho; Shigeru Sakiyama
Discordant production of released exogenous protein and infectious virions from retrovirus-packaging cells used for gene transduction.
Anticancer research 1997;17(6D):4415-7.
1997: Tatsuo Kanda; Osamu Yokosuka; Fumio Imazeki; Masatoshi Tagawa; T Ehata; Hiromitsu Saisho; Masao Omata
GB virus-C RNA in Japanese patients with hepatocellular carcinoma and cirrhosis.
Journal of hepatology 1997;27(3):464-9.
1997: Yasuo Iwadate; H Namba; Masatoshi Tagawa; Keizo Takenaga; K Sueyoshi; Shigeru Sakiyama
Induction of acquired immunity in rats that have eliminated intracranial gliosarcoma cells by the expression of herpes simplex virus-thymidine kinase gene and ganciclovir administration.
Oncology 1997;54(4):329-34.
1997: Yasuo Iwadate; S Fujimoto; K Sueyoshi; H Namba; Masatoshi Tagawa; Akira Yamaura
Prediction of drug cytotoxicity in 9L rat brain tumor by using flow cytometry with a deoxyribonucleic acid-binding dye.
Neurosurgery 1997;40(4):782-7; discussion 787-8.
1997: M Kimura; Masatoshi Tagawa; Keizo Takenaga; Taketo Yamaguchi; Hiromitsu Saisho; Akira Nakagawara; Shigeru Sakiyama
Inability to induce the alteration of tumorigenicity and chemosensitivity of p53-null human pancreatic carcinoma cells after the transduction of wild-type p53 gene.
Anticancer research 1997;17(2A):879-83.
1997: Y Gunji; Masatoshi Tagawa; H Matsubara; Keizo Takenaga; H Shimada; Fukuo Kondo; T Suzuki; K Nakajima; M Sugaya; T Asano; Takenori Ochiai; K Isono; H Kageyama; Y Nakamura; Shigeru Sakiyama
Antitumor effect of murine colon carcinoma cells retrovirally transduced with interleukin-4 and granulocyte macrophage-colony stimulating factor genes.
Oncology 1997;54(1):69-73.
1996: Yoshio Gunji; Masatoshi Tagawa; Hisahiro Matsubara; Keizo Takenaga; M Sugaya; K Tasaki; T Maeda; F Kondo; K Nakajima; Takeo Suzuki; Takehide Asano; Takenori Ochiai; K Isono; Shigeru Sakiyama
Inhibition of peritoneal dissemination of colon carcinoma in syngeneic mice immunized with interleukin-2-producing cells.
Cancer letters 1996;109(1-2):171-6.
1996: H Namba; Yasuo Iwadate; Masatoshi Tagawa; M Kimura; H Shimizu; Y Sato; K Sueyoshi; Shigeru Sakiyama
Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging.
Human gene therapy 1996;7(15):1847-52.
1996: Yasuo Iwadate; S Fujimoto; Masatoshi Tagawa; H Namba; K Sueyoshi; M Hirose; Shigeru Sakiyama
Association of p53 gene mutation with decreased chemosensitivity in human malignant gliomas.
International journal of cancer. Journal international du cancer 1996;69(3):236-40.
1996: Yoshio Gunji; Masatoshi Tagawa; Hisahiro Matsubara; Keizo Takenaga; H Shimada; F Kondo; Takeo Suzuki; K Nakajima; M Sugaya; Takehide Asano; Takenori Ochiai; K Isono; K Horitsu; H Kageyama; Y Nakamura; Shigeru Sakiyama
Antitumor effect induced by the expression of granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cells.
Cancer letters 1996;101(2):257-61.
1996: Yoshio Gunji; Masatoshi Tagawa; Hisahiro Matsubara; K Takenaga; H Shimada; F Kondo; Takeo Suzuki; K Nakajima; T Aoki; Takehide Asano; Takenori Ochiai; K Isono; H Kageyama; Y Nakamura; Shigeru Sakiyama
Murine colon carcinoma cells engineered to produce human interleukin-2 induce tumor-specific anti-tumor response.
International journal of cancer. Journal international du cancer 1996;66(1):135-9.
1996: Masatoshi Tagawa; Osamu Yokosuka; Fumio Imazeki; M Ohto; Masao Omata
Gene expression and active virus replication in the liver after injection of duck hepatitis B virus DNA into the peripheral vein of ducklings.
Journal of hepatology 1996;24(3):328-34.
1996: Hisahiro Matsubara; Masatoshi Tagawa; Yoshio Gunji; Keizo Takenaga; M Sugaya; T Urashima; Y Koide; Takeo Suzuki; Takehide Asano; Takenori Ochiai; K Isono; H Kageyama; Y Nakamura; Shigeru Sakiyama
Study of irradiation effects on cytokine secretion from retrovirally-transduced tumor cells: a model for tumor vaccination.
Anticancer research 1996;16(2):645-50.
1995: S Takano; Osamu Yokosuka; Fumio Imazeki; Masatoshi Tagawa; Masao Omata
Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients.
Hepatology (Baltimore, Md.) 1995;21(3):650-5.
1991: Masao Omata; Y Ito; Osamu Yokosuka; Fumio Imazeki; Masatoshi Tagawa; S Takano; K Hosoda; M Tada; M Ohto; K Ito
Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant alpha-interferon for chronic non-A, non-B hepatitis.
Digestive diseases and sciences 1991;36(9):1217-22.
1991: Toshihiko Iizasa; Y Yamaguchi; Masatoshi Tagawa; T Fujisawa; H Saito; H Kondo; Y Matsuo; J Minowada; Masaru Taniguchi
Human monoclonal antibody detects a cell surface antigen expressed on hematopoietic malignant cells of lymphoid lineage.
Japanese journal of cancer research : Gann 1991;82(2):213-8.
1990: Masatoshi Tagawa; T Sakamoto; K Shigemoto; H Matsubara; Y Tamura; T Ito; I Nakamura; A Okitsu; K Imai; Masaru Taniguchi
Expression of novel DNA-binding protein with zinc finger structure in various tumor cells.
The Journal of biological chemistry 1990;265(32):20021-6.
1990: Masatoshi Tagawa; Masao Omata; P L Marion
Open reading frames on plus strand genome of duck hepatitis B virus.
Gastroenterologia Japonica 1990;25 Suppl 2():20-2.
1990: Masao Omata; M Tada; K Hosoda; S Takano; Masatoshi Tagawa; Fumio Imazeki; Osamu Yokosuka; Y Ito; M Ohto
[Long-term treatment for non-A, non-B chronic hepatitis--effects on hepatitis C virus (HCV)].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 1990;87(6):1430-5.
1989: I Kuwabara; Masatoshi Tagawa; Y Harada; T Ito; Masaru Taniguchi
Properties of mouse melanoma antigen and its secretion mechanism from the cell surface.
Japanese journal of cancer research : Gann 1989;80(10):981-7.
1989: Masaru Taniguchi; S Wakabayashi; Masatoshi Tagawa
Syngeneic monoclonal antimelanoma antibodies and their application for analysis of tumor antigens, gene cloning, and in vitro/in vivo diagnosis.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 1989;2(4):254-8.
1989: Masatoshi Tagawa; T Sakamoto; Y Tamura; K Imai; T Ito; H Matsubara; M Kanno; K Shigemoto; Haruhiko Koseki; Masaru Taniguchi
Genomic DNA with transformation-related activity and melanoma antigen expression.
The Journal of investigative dermatology 1989;92(5 Suppl):284S-288s.
1988: A Okitsu; Masatoshi Tagawa; Y Tamura; M Kanno; H Matsubara; T Ito; K Imai; K Shigemoto; I Nakamura; Haruhiko Koseki
Isolation of genomic DNA controlling mouse melanoma antigen defined by monoclonal antibody.
Japanese journal of cancer research : Gann 1988;79(6):718-25.
1988: Masatoshi Tagawa; T Ito; M Kanno; A Okitsu; T Sakamoto; K Imai; I Kuwabara; Haruhiko Koseki; H Matsubara; Y F Lau
Method of genomic DNA cloning by the combination of cosmid shuttle vector and monoclonal antibody.
Microbiology and immunology 1988;32(10):1073-8.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.